Featured Posters & Presentations
Lyfgenia
Update on the first patients with severe hemoglobinopathies treated with LentiGlobin gene therapy [Poster]. Abstract published in Haematologica. 2017;102(s2):248.
Authors: Ribeil JA.
Zynteglo
A phase 3 study to evaluate safety and efficacy of LentiGlobin gene therapy for transfusion-dependent β-thalassemia in patients with non-β0/β0 genotypes: the Northstar-2 (HGB-207) trial.
Authors: Walters MC.